Australia's Sigma Pharmaceuticals Ltd. <SIP.AX> said on Thursday it is still interested in acquiring the A$1 billion ($840 million) consumer and pharmacy businesses of Symbion Health Ltd. <SYB.AX>.

Sigma Pharmaceuticals hopes to finalise a proposal to buy Symbion Health's consumer and pharmacy business by Monday, despite the target company announcing yesterday it wasn't taking the indicative ...

Symbion Health says a proposal by Sigma and a private equity consortium to acquire Symbion's pharmacy services lacks sufficient information. Symbion says need more info from Sigma.

Australia's Symbion Health Ltd. <SYB.AX> said on Tuesday that Sigma Pharmaceuticals Ltd. <SIP.AX> offered A$1.085 billion ($912 million) for its consumer and pharmacy businesses, trumping a rival ...

TAKEOVER target Symbion Health has rebuffed Sigma Pharmaceuticals' attempt to muscle in with a higher but incomplete $1.08 billion offer for its pharmacy and consumer products business.

TAKEOVER target Symbion Health has rebuffed the attempt of Sigma Pharmaceuticals to muscle in with a higher, but incomplete, $1.08 billion offer for its pharmacy and consumer products business.

Sigma last Wednesday made a $1.085 billion indicative proposal, in conjunction with Carnegie, Wylie & Co and Sun Super, to buy part of Symbion's business, but Symbion dismissed it as incomplete.

The battle for control of Symbion Health has taken another twist with Sigma Pharmaceuticals launching a billion dollar bid. Skip to main content. ABC News ... Symbion future uncertain after new offer.

Australia’s Sigma Pharmaceuticals on Thursday emerged as a potential bidder for the pharmacy services and consumer businesses of domestic rival Symbion Health, potentially creating an obstacle ...

Add articles to your saved list and come back to them any time. SYMBION Health wants to make rival Sigma Pharmaceuticals pay a high price for pharmacy wholesaler Australian Pharmaceutical ...

SIGMA Pharmaceuticals has approached Symbion Health with a $1.085 billion takeover offer to buy its consumer and pharmacy business, a newspaper reported today.

Add articles to your saved list and come back to them any time. Pathology, medical centre and drugs group Symbion Health Ltd says a proposal by Sigma Pharmaceuticals Ltd and a private equity ...